Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce
Share · US1101221406 · CELG-RI (XNYS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - - - -

Company Profile for Bristol-Myers Squibb Company Ce Share

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Company Data

Name Bristol-Myers Squibb Company Ce
Company Bristol-Myers Squibb Company Ce
Symbol CELG-RI
Website http://www.bms.com
Primary Exchange XNYS NYSE
ISIN US1101221406
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
Market Capitalization 84 Mrd.
Country United States of America
Currency USD
Employees 34,1 T
Address , Princeton

Ticker Symbols

Name Symbol
NYSE CELG-RI

More Shares

Investors who hold Bristol-Myers Squibb Company Ce also have the following shares in their portfolio:
CONST.BRANDS 18/23
CONST.BRANDS 18/23 Bond
ISRAEL 18/28
ISRAEL 18/28 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025